Curcumin inhibits the proliferation and mineralization of cultured osteoblasts

European Journal of Pharmacology

Volumn 534, Issue 1-3, 2006, Pages 55-62

  Notoya, Michitaka ^a   Nishimura, Hiroyuki ^b   Woo, Je Tae ^c   Nagai, Kazuo ^c   Ishihara, Yoko ^d   Hagiwara, Hiromi ^a,b  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b TOIN UNIVERSITY OF YOKOHAMA   (Japan)

^c CHUBU UNIVERSITY   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Curcumin; Mineralization; Osteoblasts; p21; Polyphenol; Proliferation

Indexed keywords

CALCIUM; CURCUMIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; HISTONE H1; POLYPHENOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE METABOLISM; CELL CULTURE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CURCUMA LONGA; ENZYME ASSAY; FLOW CYTOMETRY; IN VITRO STUDY; MINERALIZATION; NEWBORN; NONHUMAN; OSTEOBLAST; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHIZOME; STAINING;

ANIMALS; ANIMALS, NEWBORN; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CURCUMIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; OSTEOBLASTS; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS;

EID: 33644887126     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.01.028     Document Type: Article

References (38)

1. Y. Abe, S. Hashimoto, and T. Horie Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages Pharmacol. Res. 39 1999 41 47
2. B.B. Aggarwal, A. Kumar, and A.C. Bharati Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res. 23 2003 363 398
3. R.J. Anto, A. Mukhopadhyay, K. Denning, and B.B. Aggarwal Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl Carcinogenesis 23 2002 143 150
4. M. Belakavadi, and B.P. Salimath Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-kB and caspase activated Dnase Mol. Cell. Biochem. 273 2005 57 67
5. WAF1/CIP1 acts as a brake in osteoblast differentiation J. Bone Miner. Res. 18 2003 818 826
6. A.C. Bharti, N. Donato, S. Singh, and B.B. Aggarwal Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-κB and I-κBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis Blood 101 2003 1053 1062
7. A.C. Bharti, Y. Takada, and B.B. Aggarwal Curcumin (diferuloylmethane) inhibits receptor activator of NF-κB ligand-induced NF-κB activation in osteoclast precursors and suppresses osteoclastogenesis J. Immunol. 172 2004 5940 5947
8. J.A. Bush Jr., K.J. Cheung, and G. Li Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53 Exp. Cell Res. 271 2001 305 314
9. H.W. Chen, and H.C. Huang Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells Br. J. Pharmacol. 124 1998 1029 1040
10. A. Chen, and J. Xu Activation of PPARγby curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR Am. J. Physiol. 288 2005 G447 G456
11. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control Cell 82 1995 675 684
12. T. Dorai, and B.B. Aggarwal Role of chemopreventive agents in cancer therapy Cancer Lett. 215 2004 129 140
13. A. Goel, C.R. Boland, and D.P. Chauhan Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells Cancer Lett. 172 2001 111 118
14. H. Hagiwara, A. Inoue, A. Yamaguchi, S. Yokose, M. Furuya, S. Tanaka, and S. Hirose cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells Am. J. Physiol. 270 1996 C1311 C1318
15. H. Hagiwara, M. Naruse, C. Adachi, A. Inoue, Y. Hiruma, E. Otsuka, K. Naruse, H. Demura, and S. Hirose Ipriflavone down-regulates the expression of endothelin receptors during the differentiation of rat calvarial osteoblast-like cells J. Biochem. 126 1999 168 173
16. E.R. Hahm, G. Cheon, J. Lee, B. Kim, C. Park, and C.H. Yang New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex Cancer Lett. 184 2002 89 96
17. Y. Hiruma, A. Inoue, A. Shiohama, E. Otsuka, S. Hirose, A. Yamaguchi, and H. Hagiwara Endothelins inhibit the mineralization of osteoblastic MC3T3-E1 cells through the A-type endothelin receptor Am. J. Physiol. 275 1998 R1099 R1105
18. J. Hong, M. Bose, J. Ju, J.H. Ryu, X. Chen, S. Sang, M.J. Lee, and C.S. Yang Modulation of arachidonic acid metabolism by curcumin and related β-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase Carcinogenesis 25 2004 1671 1679
19. WAF1/CIP1 and C/EBPβ expressions and suppressing NF-κB activation Prostate 51 2002 211 218
20. T.S. Huang, S.C. Lee, and J.K. Lin Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells Proc. Natl. Acad. Sci. U. S. A. 88 1991 5292 5296
21. C. Jobin, C.A. Bradham, M.P. Russo, B. Juma, A.S. Narula, D.A. Brenner, and R.B. Sartor Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity J. Immunol. 163 1999 3474 3483
22. W. Jochum, J.P. David, C. Elliott, A. Wutz, H. Plenk Jr., K. Matsuo, and E.F. Wagner Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1 Nat. Med. 6 2000 980 984
23. D. Karunagaran, R. Rashmi, and T.R. Kumar Induction of apoptosis by curcumin and its implications for cancer therapy Curr. Cancer Drug Targets 5 2005 117 129
24. A. Liontas, and H. Yeger Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma Anticancer Res. 24 2004 987 998
25. M. Naruse, Y. Ishihara, S. Miyagawa-Tomita, A. Koyama, and H. Hagiwara 3-Methylcholanthrene, which binds to the arylhydrocarbon receptor, inhibits proliferation and differentiation of osteoblasts in vitro and ossification in vivo Endocrinology 143 2002 3575 3581
26. M. Notoya, Y. Tsukamoto, H. Nishimura, J.T. Woo, K. Nagai, I.S. Lee, and H. Hagiwara Quercetin, a flavonoid, inhibits the proliferation, differentiation, and mineralization of osteoblasts in vitro Eur. J. Pharmacol. 485 2004 89 96
27. M.H. Pan, S.Y. Lin-Shiau, and J.K. Lin Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IκB kinase and NF-κB activation in macrophages Biochem. Pharmacol. 60 2000 1665 1676
28. KIP1 and p53 Int. J. Oncol. 21 2002 379 383
29. N.C. Partridge, D. Alcorn, V.P. Michelangeli, B.E. Kemp, G.B. Ryan, and T.J. Martin Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells Endocrinology 108 1981 213 351
30. S.M. Plummer, K.A. Holloway, M.M. Manson, R.J. Munks, A. Kaptein, S. Farrow, and L. Howells Inhibition of cyclo-oxygenase-2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signaling complex Oncogene 18 1999 6013 6020
31. B.K. Prusty, and B.C. Das Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin Int. J. Cancer 113 2005 951 960
32. B.L. Riggs Pathogenesis of osteoporosis Am. J. Obstet. Gynecol. 156 1987 1342 1346
33. G. Sabatakos, N.A. Sims, J. Chen, K. Aoki, M.B. Kelz, M. Amling, Y. Bouali, K. Mukhopadhyay, K. Ford, E.J. Nestler, and R. Baron Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis Nat. Med. 6 2000 985 990
34. Y. Tsukamoto, Y. Ishihara, S. Miyagawa-Tomita, and H. Hagiwara Tributyltin inhibits ossification in vivo and differentiation of osteoblasts in vitro Biochem. Pharmacol. 68 2004 739 746
35. A. Wattel, S. Kamel, R. Mentaverri, F. Lorget, C. Prouillet, J.P. Petit, P. Fardelonne, and M. Brazier Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption Biochem. Pharmacol. 65 2003 35 42
36. T. Yamagishi, E. Otsuka, and H. Hagiwara Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: evidence for the involvement of topoisomerase II in osteoclastogenesis Endocrinology 142 2001 3632 3637
37. S. Yuhara, S. Kasagi, A. Inoue, E. Otsuka, S. Hirose, and H. Hagiwara Effects of nicotine on cultured cells suggest that it can influence the formation and resorption of bone Eur. J. Pharmacol. 383 1999 387 393
38. M. Zheng, S. Ekmekcioglu, E.T. Walch, C.H. Tang, and E.A. Grimm Inhibition of NF-κB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells Melanoma Res. 14 2004 165 171